Doctor Liu has been engaged in pediatric hematology and oncology for over 30 years. Since 1995, she has worked in the Pediatric Hematology and Oncology Department of the PLA General Hospital for more than 20 years, and in 2019, she joined the Pediatric Hematology and Oncology Department of Beijing GoBroad Boren Hospital.

She is skilled in the diagnosis and treatment of various pediatric hematologic oncological diseases and has rich clinical experience in chemotherapy for hematological diseases and the management of critical illness. She specializes in chemotherapy and immunotherapy for pediatric leukemia and lymphoma. She has led or participated in multiple clinical research studies and scientific projects, including a Phase II clinical trial on sequential CAR-T therapy targeting different B-cell antigens for children and adolescents with refractory relapsed B-cell lymphoma; early warning and intervention research for pediatric post-recovery encephalopathy; and the screening and analysis of tumor-associated antigens and their encoding genes related to neuroblastoma. She has published over 20 papers as the first author in core journals and 3 papers in SCI journals.